Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes

Association of Serum Fibroblast Growth Factor 23 Levels with the Presence and Severity of Hepatic Steatosis Is Independent of Sleep Duration in Patients with Diabetes

Xiang Hu, Lijuan Yang, Weihui Yu, Wei Pan, Xueqin Chen, Qianqian Li, Jingzong Zhou, Xuejiang Gu Department of Endocrine and Metabolic Diseases, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, People’s Republic of ChinaCorrespondence: Xuejiang GuDepartment of Endocrine...

Full description

Bibliographic Details
Main Authors: Hu X, Yang L, Yu W, Pan W, Chen X, Li Q, Zhou J, Gu X
Format: Article
Language:English
Published: Dove Medical Press 2020-04-01
Series:Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy
Subjects:
fibroblast growth factor 23
hepatic steatosis
controlled attenuation parameters
sleep duration
Online Access:https://www.dovepress.com/association-of-serum-fibroblast-growth-factor-23-levels-with-the-prese-peer-reviewed-article-DMSO

Internet

https://www.dovepress.com/association-of-serum-fibroblast-growth-factor-23-levels-with-the-prese-peer-reviewed-article-DMSO

Similar Items